Singapore markets open in 5 hours 32 minutes

Beijing Tiantan Biological Products Co., Ltd. (600161.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
24.82-0.14 (-0.56%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 49.08B
Enterprise value 44.37B
Trailing P/E 42.55
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.70
Price/book (mrq)4.84
Enterprise value/revenue 8.68
Enterprise value/EBITDA 23.53

Trading information

Stock price history

Beta (5Y monthly) 0.31
52-week change 313.16%
S&P500 52-week change 326.24%
52-week high 327.27
52-week low 319.17
50-day moving average 324.57
200-day moving average 323.82

Share statistics

Avg vol (3-month) 314.14M
Avg vol (10-day) 320.19M
Shares outstanding 51.98B
Implied shares outstanding 61.98B
Float 8949.59M
% held by insiders 154.49%
% held by institutions 115.68%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.15
Forward annual dividend yield 40.60%
Trailing annual dividend rate 30.12
Trailing annual dividend yield 30.50%
5-year average dividend yield 40.26
Payout ratio 47.14%
Dividend date 3N/A
Ex-dividend date 420 Jun 2024
Last split factor 21.2:1
Last split date 320 Jun 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 22.79%
Operating margin (ttm)40.25%

Management effectiveness

Return on assets (ttm)7.88%
Return on equity (ttm)12.71%

Income statement

Revenue (ttm)5.11B
Revenue per share (ttm)2.56
Quarterly revenue growth (yoy)-5.40%
Gross profit (ttm)N/A
EBITDA 2.05B
Net income avi to common (ttm)1.16B
Diluted EPS (ttm)0.58
Quarterly earnings growth (yoy)20.90%

Balance sheet

Total cash (mrq)4.75B
Total cash per share (mrq)2.4
Total debt (mrq)42.22M
Total debt/equity (mrq)0.32%
Current ratio (mrq)5.53
Book value per share (mrq)5.13

Cash flow statement

Operating cash flow (ttm)2.24B
Levered free cash flow (ttm)664.91M